Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: " Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?. | Radiation Oncology BioMed Central Open Access Short report Intensity modulated radiotherapy for localized prostate cancer rigid compliance to dose-volume constraints as a warranty of acceptable toxicity Michael J Chen 1 Eduardo Weltman1 2 Rodrigo M Hanriot1 Fábio P Luz1 Paulo J Cecílio1 José C da Cruz1 Frederico R Moreira3 Adriana S Santos1 Lidiane C Martins1 and Wladmir Nadalin1 2 Address Department of Radiation Oncology Hospital Israelita Albert Einstein Av. Albert Einstein 627 701 - Sao Paulo Brazil 2Department of Radiation Oncology Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Av. Dr. Enéas de Carvalho Aguiar 255 - Sao Paulo Brazil and 3Instituto Israelita de Ensino e Pesquisa Av. Albert Einstein 627 701 - Sao Paulo Brazil Email Michael J Chen - Eduardo Weltman - eweltman@ Rodrigo M Hanriot - hanriot@ Fábio P Luz - michaelchen@ Paulo J Cecílio - josecarlosc@ José C da Cruz - josecarlosc@ Frederico R Moreira - fredericorm@ Adriana S Santos - michaelchen@ Lidiane C Martins - michaelchen@ Wladmir Nadalin - wladimirn@ Corresponding author Published 15 January 2007 Radiation Oncology 2007 2 6 doi 1748-7I7X-2-6 Received 14 October 2006 Accepted 15 January 2007 This article is available from http content 2 1 6 2007 Chen et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background To report the toxicity after intensity modulated radiotherapy IMRT for patients with localized prostate cancer as a sole treatment or after radical prostatectomy. Methods Between August 2001 and December 2003 132 patients with prostate cancer were treated with .
